Search

Olumi, A. F., and W. C. Dewolf. 2009. The Hybrid of Basic Science and Clinical Training for the Urologic Oncologist: Necessity or Waste?.

Zhang, X., X. Huang, and A. F. Olumi. 2009. Repression of NF-KappaB and Activation of AP-1 Enhance Apoptosis in Prostate Cancer Cells.

Niu, Y., R. Ge, L. Hu, C. Diaz, Z. Wang, C. L. Wu, and A. F. Olumi. 2011. Reduced Levels of 5-α Reductase 2 in Adult Prostate Tissue and Implications for BPH Therapy.

Wang, Z., Z. Cheng, V. Cristofaro, J. Li, X. Xiao, P. Gomez, R. Ge, et al. 2012. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes.

Fendt, S. M., E. L. Bell, M. A. Keibler, S. M. Davidson, G. J. Wirth, B. Fiske, J. R. Mayers, et al. 2013. Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism.

Olumi, A. F., D. S. Kaufman, A. Zietman, M. G. Harisinghani, and C. L. Wu. 2013. Case Records of the Massachusetts General Hospital. Case 25-2013. A 71-Year-Old Man With Hematuria and a Mass in the Bladder.

Aizer, A. A., J. J. Paly, M. D. Michaelson, S. K. Rao, P. L. Nguyen, I. D. Kaplan, A. Niemierko, A. F. Olumi, and J. A. Efstathiou. 2014. Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer.

Preston, M. A., A. H. Riis, V. Ehrenstein, R. H. Breau, J. L. Batista, A. F. Olumi, L. A. Mucci, H. O. Adami, and H. T. Sørensen. 2014. Metformin Use and Prostate Cancer Risk.

Rodríguez, D., M. A. Preston, G. W. Barrisford, A. F. Olumi, and A. S. Feldman. 2014. Clinical Features of Leiomyosarcoma of the Urinary Bladder: Analysis of 183 Cases.

Ingham, M. D., R. J. Lee, D. MacDermed, and A. F. Olumi. 2018. Prostate Cancer in Transgender Women.